Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 30 peer-reviewed journal articles Updated
Gynecology · Uterine Fibroids

How Are Fibroids Distinguished from Other Pelvic Conditions?

At a Glance

Symptoms and physical examination alone cannot reliably distinguish uterine fibroids from adenomyosis, polyps, endometriosis, or ovarian masses. Doctors combine bleeding and pain patterns with ultrasound, MRI, and sometimes a camera exam or biopsy to identify the cause and look for serious disease.

In this answer

3 sections

01

Symptom Clues and Examination Findings

02

How Imaging and Procedures Clarify the Picture

03

Red Flags: Ruling Out Endometrial and Ovarian Disease

Because conditions like fibroids, adenomyosis, endometriosis, polyps, and ovarian cysts often cause similar symptoms—such as heavy bleeding and pelvic pain—they cannot be reliably distinguished by your symptoms or a physical examination alone [1][2]. In fact, these conditions frequently coexist in the same person, making diagnosis even more complex [2][3]. To tell them apart, doctors rely on matching your specific pattern of bleeding and pain with targeted imaging tests, like transvaginal ultrasound or MRI, and sometimes tissue biopsies. These tools help confirm the exact diagnosis and evaluate for more serious diseases. Importantly, most of these conditions—including fibroids, polyps, and many ovarian cysts—are benign (non-cancerous).

When to Seek Urgent Care

While most pelvic symptoms can be evaluated at a scheduled appointment, you should seek urgent or emergency care if you experience:

  • Rapid, heavy bleeding accompanied by dizziness, fainting, shortness of breath, or weakness (signs of severe blood loss)
  • Sudden, severe, or one-sided pelvic pain
  • Pelvic pain accompanied by a fever
  • Pelvic symptoms when you might be pregnant (to evaluate for an ectopic pregnancy)

Symptom Clues and Examination Findings

While symptoms overlap, certain patterns provide important diagnostic clues to your care team:

  • Uterine Fibroids: Typically cause heavy or prolonged menstrual bleeding, pelvic pressure, and “bulk” symptoms (like feeling full or having to pee frequently) [1]. Depending on their location (such as submucosal if inside the cavity, or intramural if in the muscle wall), symptoms can vary. On a physical exam, your doctor might feel an enlarged or irregularly shaped uterus.
  • Adenomyosis: This occurs when the uterine lining grows into the muscular wall of the uterus. It often causes very heavy bleeding combined with marked dysmenorrhea (painful periods) and chronic pelvic pain [4]. The uterus may feel uniformly enlarged and tender during an exam, but this alone cannot definitively separate it from fibroids [4].
  • Endometrial Polyps: These are overgrowths of the uterine lining. They are often painless but are a classic cause of intermenstrual bleeding (spotting between periods) [5].
  • Endometriosis: This condition involves tissue similar to the uterine lining growing outside the uterus. The presence of endometriosis may be suggested by cyclical pain, deep pain during sex (dyspareunia), painful bowel movements or urination, and potential fertility challenges [6]. However, pain may be noncyclic or absent for some people.
  • Ovarian Masses: Ovarian cysts or tumors can cause pelvic pain, bloating, or a mass near the ovaries [7]. Sometimes a fibroid growing outward off the side of the uterus can mimic an ovarian mass on a physical exam, making imaging essential [8].

How Imaging and Procedures Clarify the Picture

Because physical exams are limited, doctors use specific tests to see exactly where the problem is located and what tissues are involved. A standard evaluation may also include a pregnancy test or a blood count to check for anemia.

Transvaginal Ultrasound (TVUS)

This is the first-line imaging test for abnormal bleeding and pelvic pain [9]. You can expect the provider to gently insert an ultrasound wand into the vagina; this may cause mild pressure or discomfort. TVUS is excellent at spotting structural issues and may detect or suggest fibroids, polyps, signs of adenomyosis, and specific ovarian cysts called endometriomas [10][11]. However, it has limitations: standard ultrasound can miss small polyps, subtle adenomyosis, or superficial endometriosis, and its accuracy drops if you have multiple conditions at once [12][13].

Saline Infusion Sonography (SIS)

Also known as a sonohysterogram, this test involves gently placing sterile saline fluid into the uterus through a thin tube during an ultrasound. You may experience cramping or spotting during and after the test. The fluid separates the uterine walls, making SIS significantly more accurate than a standard TVUS at finding and measuring growths inside the uterine cavity, such as polyps and submucosal fibroids [14][15].

Magnetic Resonance Imaging (MRI)

MRI is a problem-solving tool used when ultrasound results are unclear [16]. It uses no radiation but requires lying still in a tube, which can trigger claustrophobia. It is highly valuable for mapping the exact size and location of fibroids before surgery, evaluating complex adenomyosis, finding deep infiltrating endometriosis, and determining whether a pelvic mass is attached to the ovary or the uterus [17][18].

Hysteroscopy and Biopsy

While imaging shows what a growth looks like, it cannot tell you exactly what kind of cells it is made of. Tissue must be examined under a microscope (histopathology) to evaluate for precancerous changes or cancer.

  • Endometrial Biopsy: This is a blind sampling often done in the office, which can cause strong but brief cramping. It is a useful first-line test for diffuse uterine lining issues, but it can completely miss focal growths like polyps [19][20].
  • Hysteroscopy: If a focal lesion is suspected or bleeding persists after a blind biopsy, hysteroscopy may be recommended. A thin, lighted camera is inserted into the uterus to look directly at the cavity and allow for targeted sampling or removal of a specific lesion [21][22][23].

Red Flags: Ruling Out Endometrial and Ovarian Disease

A major goal of evaluating pelvic symptoms is to ensure the problem is benign and not a hidden malignancy. Your doctor will look for specific “red flags” that require a deeper look:

  • Endometrial Disease: Any bleeding after menopause requires prompt medical evaluation. An initial ultrasound is often used; if the uterine lining is thickened (often greater than 4 mm), cannot be adequately seen, or if bleeding persists or recurs, a tissue biopsy is usually required [19][24]. For premenopausal patients, an endometrial biopsy is commonly recommended for abnormal bleeding at age 45 or older. For younger patients, biopsy may be recommended if bleeding is persistent, medical treatment fails, or if there is a substantial risk of unopposed estrogen exposure (such as chronic anovulation or PCOS) [25]. Additional risk factors like obesity, diabetes, and family history also help individualize this decision [24].
  • Ovarian Disease: If imaging shows an adnexal (ovary or fallopian tube area) mass with suspicious features—such as solid components, abnormal blood flow, or fluid in the abdomen (ascites)—this may prompt expedited specialist assessment or a referral to a gynecologic oncologist [26][27][28]. However, many adnexal masses are benign, and referrals depend on the complete ultrasound appearance, menopausal status, and blood tests like CA-125.
  • Uterine Sarcoma Clues: Uterine sarcomas are rare cancers that can look very similar to fibroids on imaging. While no single feature reliably distinguishes a sarcoma from a benign fibroid, a new or rapidly enlarging uterine mass after menopause, or genuinely suspicious MRI features (like ill-defined tumor borders), merit specialist evaluation [29][30]. Definitive diagnosis always depends on pathology.

Common questions in this guide

Can symptoms alone tell whether I have fibroids or another pelvic condition?
No. Fibroids, adenomyosis, polyps, endometriosis, and ovarian masses can cause overlapping bleeding and pain, and more than one condition can occur at the same time. Doctors usually combine your symptom pattern, examination, and imaging to determine the cause.
How do doctors distinguish fibroids from adenomyosis?
Symptoms may provide clues, but a physical examination alone cannot reliably separate these conditions. Transvaginal ultrasound is usually the first imaging test, while MRI can provide more detail when ultrasound findings are unclear or adenomyosis is complex.
What symptoms can suggest endometriosis rather than fibroids?
Cyclical pelvic pain, deep pain during sex, painful bowel movements or urination, and difficulty becoming pregnant can suggest endometriosis. However, pain may occur outside the menstrual cycle or be absent, and standard ultrasound can miss superficial endometriosis.
What test is best for finding a polyp or fibroid inside the uterine cavity?
Transvaginal ultrasound may detect these growths, but a saline infusion sonogram uses sterile fluid to outline the uterine cavity and is more accurate for polyps and fibroids that grow into the cavity. If a focal growth is suspected or bleeding continues, hysteroscopy allows direct viewing, targeted sampling, or removal.
Can a fibroid be mistaken for an ovarian mass, and when is MRI useful?
Yes. A fibroid growing outward from the uterus can resemble an ovarian mass, so imaging is important. MRI can help show whether a mass is attached to the uterus or ovary and can clarify complex pelvic findings when ultrasound is uncertain. Many ovarian masses are benign, but suspicious features may require specialist assessment.
Can an endometrial biopsy rule out a polyp or other uterine growth?
Not always. An office endometrial biopsy samples tissue without directly viewing the entire uterine cavity, so it can miss a focal growth such as a polyp. Hysteroscopy may be recommended when a focal lesion is suspected or bleeding persists because it permits targeted sampling.
When should pelvic bleeding or pain be evaluated urgently?
Seek urgent or emergency care for rapid, heavy bleeding with dizziness, fainting, shortness of breath, or weakness; sudden severe or one-sided pelvic pain; or pelvic pain with fever. Seek prompt care when pelvic symptoms occur during a possible pregnancy because an ectopic pregnancy must be considered.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Related questions

What Do Hybrid FIGO 2-5, 3-5, or 2-6 Uterine Fibroids Mean? When is Heavy Bleeding from Uterine Fibroids an Emergency? When Should I Have MRI, SIS, or Hysteroscopy for Fibroids? Can Uterine Fibroids Cause Fatigue and Shortness of Breath? When Is Severe Uterine Fibroid Pain or Fever an Emergency?
Show more
Can Uterine Fibroids Cause Painful Sex or Sexual Changes? Can Fibroids Cause Abdominal Enlargement or Weight Gain? Do I Need an Endometrial Biopsy for Fibroid Bleeding? Does Rapid Fibroid Growth Mean Uterine Cancer? Signs to Know How Is Postmenopausal Bleeding Evaluated With Fibroids? How Are Cavity-Distorting Fibroids Treated Before IVF? What Blood Tests Are Needed for Anemia From Fibroids? Do Uterine Fibroids Become Cancerous or Raise Cancer Risk? Can Fibroids Cause Constipation, Bloating or Urinary Issues? Can Asymptomatic Uterine Fibroids Be Safely Left Untreated? Do Uterine Fibroids Run in Families? Screening Advice Do Uterine Fibroids Shrink Before or After Menopause? Can Diet, Exercise, or Supplements Shrink Fibroids? Why Are Fibroids More Common and Severe in Black Women?

Get notified when new evidence is published on uterine corpus leiomyoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my ultrasound, are there signs of other conditions like adenomyosis or polyps in addition to fibroids?
  2. 2.Would a saline infusion sonogram (SIS) or MRI give us a better picture of exactly what is causing my symptoms?
  3. 3.Based on my specific bleeding pattern, age, and personal health history, is an endometrial biopsy recommended for me?
  4. 4.Are any of the growths you see located inside the uterine cavity, and would a hysteroscopy be the best way to evaluate them?
  5. 5.If my biopsy results are negative or inconclusive but my symptoms continue, what is our next step?

References

References (30)
  1. 1

    Uterine Fibroids: Diagnosis and Treatment.

    De La Cruz MS, Buchanan EM

    American family physician 2017; (95(2)):100-107.

    PMID: 28084714
  2. 2

    Adenomyosis and Uterine Fibroids: Two Distinct Yet Overlapping Clinical Entities.

    Pecorella G, Morciano A, Medvediev M, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(18)) doi:10.3390/diagnostics16182968.

    PMID: 42793753
  3. 3

    Imaging for evaluation of endometriosis and adenomyosis.

    Bordonné C, Puntonet J, Maitrot-Mantelet L, et al.

    Minerva obstetrics and gynecology 2021; (73(3)):290-303 doi:10.23736/S2724-606X.21.04710-9.

    PMID: 34008384
  4. 4

    Adenomyosis: the missed disease.

    Santulli P, Vannuccini S, Bourdon M, et al.

    Reproductive biomedicine online 2025; (50(4)):104837 doi:10.1016/j.rbmo.2025.104837.

    PMID: 40287215
  5. 5

    Uterine disorders and iron deficiency anemia.

    Donnez J, Carmona F, Maitrot-Mantelet L, et al.

    Fertility and sterility 2022; (118(4)):615-624 doi:10.1016/j.fertnstert.2022.08.011.

    PMID: 36182260
  6. 6

    [Definition, description, clinicopathological features, pathogenesis and natural history of endometriosis: CNGOF-HAS Endometriosis Guidelines].

    Borghese B, Santulli P, Marcellin L, Chapron C

    Gynecologie, obstetrique, fertilite & senologie 2018; (46(3)):156-167 doi:10.1016/j.gofs.2018.02.017.

    PMID: 29540335
  7. 7

    Ultrasound-Guided Diagnosis of Multiple Uterine Fibroids in a Patient With Polycystic Ovaries and Treatment With Relugolix, Estradiol, and Norethisterone Acetate.

    Acchiardo J, Maita E, Jobanputra K

    Cureus 2023; (15(5)):e39055 doi:10.7759/cureus.39055.

    PMID: 37323302
  8. 8

    Can a T2 hyperintense rim sign differentiate uterine leiomyomas from other solid adnexal masses?

    Reiter MJ, Schwope RB, Lisanti CJ, Banks NB

    Abdominal imaging 2015; (40(8)):3182-90 doi:10.1007/s00261-015-0510-0.

    PMID: 26205993
  9. 9

    Investigation and management of abnormal uterine bleeding in reproductive-aged women: a descriptive review of national and international recommendations.

    Tsakiridis I, Giouleka S, Koutsouki G, et al.

    The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 2022; (27(6)):504-517 doi:10.1080/13625187.2022.2112169.

    PMID: 36053280
  10. 10

    Preoperative Diagnosis of Symptomatic Adenomyosis: Limitations and Clinical Insights.

    Pereira M, Kumari S, Di Francesco L, et al.

    Cureus 2025; (17(12)):e100218 doi:10.7759/cureus.100218.

    PMID: 41607951
  11. 11

    Limited Added Value of Magnetic Resonance Imaging After Dynamic Transvaginal Ultrasound for Preoperative Staging of Endometriosis in Daily Practice: A Prospective Cohort Study.

    Berger JP, Rhemrev J, Smeets M, et al.

    Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2019; (38(4)):989-996 doi:10.1002/jum.14783.

    PMID: 30244483
  12. 12

    Accuracy of ultrasound signs on two-dimensional transvaginal ultrasound in prediction of adenomyosis: prospective multicenter study.

    Krentel H, Keckstein J, Füger T, et al.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2023; (62(5)):739-746 doi:10.1002/uog.26197.

    PMID: 36920431
  13. 13

    Novelties of ultrasound imaging for endometrial cancer preoperative workup.

    Capozzi VA, Rosati A, Rumolo V, et al.

    Minerva medica 2021; (112(1)):3-11 doi:10.23736/S0026-4806.20.07125-6.

    PMID: 33205640
  14. 14

    Imaging for Polyps and Leiomyomas in Women With Abnormal Uterine Bleeding: A Systematic Review.

    Maheux-Lacroix S, Li F, Laberge PY, Abbott J

    Obstetrics and gynecology 2016; (128(6)):1425-1436 doi:10.1097/AOG.0000000000001776.

    PMID: 27824761
  15. 15

    Comparison of diagnostic accuracy of saline infusion sonohysterography, transvaginal sonography, and hysteroscopy in evaluating the endometrial polyps in women with abnormal uterine bleeding: a systematic review and meta-analysis.

    Kaveh M, Sadegi K, Salarzaei M, Parooei F

    Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques 2020; (15(3)):403-415 doi:10.5114/wiitm.2020.93791.

    PMID: 32904526
  16. 16

    ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update.

    Forstner R, Thomassin-Naggara I, Cunha TM, et al.

    European radiology 2017; (27(6)):2248-2257 doi:10.1007/s00330-016-4600-3.

    PMID: 27770228
  17. 17

    Imaging techniques for evaluation of uterine myomas.

    Testa AC, Di Legge A, Bonatti M, et al.

    Best practice & research. Clinical obstetrics & gynaecology 2016; (34()):37-53.

    PMID: 26803557
  18. 18

    The Discrepancy between Preoperative Tumor Markers and Imaging Outcomes in Predicting Ovarian Malignancy.

    Shin KH, Kim HH, Yoon HJ, et al.

    Cancers 2022; (14(23)) doi:10.3390/cancers14235821.

    PMID: 36497302
  19. 19

    Endometrial biopsy: Indications, techniques and recommendations. An evidence-based guideline for clinical practice.

    Vitale SG, Buzzaccarini G, Riemma G, et al.

    Journal of gynecology obstetrics and human reproduction 2023; (52(6)):102588 doi:10.1016/j.jogoh.2023.102588.

    PMID: 37061093
  20. 20

    The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis.

    van Hanegem N, Prins MM, Bongers MY, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2016; (197()):147-55.

    PMID: 26748390
  21. 21

    Office hysteroscopy for postmenopausal women: Feasibility and correlation with transvaginal ultrasound.

    Sauvan M, Pourcelot AG, Fournet S, et al.

    Journal of gynecology obstetrics and human reproduction 2018; (47(10)):505-510 doi:10.1016/j.jogoh.2018.08.018.

    PMID: 30193870
  22. 22

    Visually Directed Hysteroscopic Biopsy in the Evaluation of Abnormal Uterine Bleeding and Postmenopausal Bleeding: A Joint Society Practice Guideline.

    Journal of minimally invasive gynecology 2026; (33(8)):1027-1040 doi:10.1016/j.jmig.2026.06.018.

    PMID: 42336133
  23. 23

    Endometrial polyps. An evidence-based diagnosis and management guide.

    Vitale SG, Haimovich S, Laganà AS, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2021; (260()):70-77 doi:10.1016/j.ejogrb.2021.03.017.

    PMID: 33756339
  24. 24

    ACOG Committee Opinion No. 734 Summary: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding.

    Obstetrics and gynecology 2018; (131(5)):945-946 doi:10.1097/AOG.0000000000002626.

    PMID: 29683904
  25. 25

    Premenopausal abnormal uterine bleeding and risk of endometrial cancer.

    Pennant ME, Mehta R, Moody P, et al.

    BJOG : an international journal of obstetrics and gynaecology 2017; (124(3)):404-411 doi:10.1111/1471-0528.14385.

    PMID: 27766759
  26. 26

    Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group.

    Timmerman D, Van Calster B, Testa A, et al.

    American journal of obstetrics and gynecology 2016; (214(4)):424-437 doi:10.1016/j.ajog.2016.01.007.

    PMID: 26800772
  27. 27

    Clinical implication for endometriosis associated with ovarian cancer.

    Torng PL

    Gynecology and minimally invasive therapy 2017; (6(4)):152-156 doi:10.1016/j.gmit.2017.08.003.

    PMID: 30254904
  28. 28

    Guideline No. 403: Initial Investigation and Management of Adnexal Masses.

    Salvador S, Scott S, Glanc P, et al.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2020; (42(8)):1021-1029.e3 doi:10.1016/j.jogc.2019.08.044.

    PMID: 32736853
  29. 29

    Preoperative clinical characteristics between uterine sarcoma and leiomyoma in patients with uterine mass, a case-control study.

    Chantasartrassamee P, Kongsawatvorakul C, Rermluk N, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2022; (270()):176-180 doi:10.1016/j.ejogrb.2022.01.013.

    PMID: 35074691
  30. 30

    MRI for diagnosing uterine sarcoma: a systematic review and meta-analysis.

    Saida T, Ueda T, Kurihara M, et al.

    Japanese journal of radiology 2026; (44(6)):976-986 doi:10.1007/s11604-026-01952-4.

    PMID: 41678008

This page explains how clinicians distinguish uterine fibroids from other pelvic conditions for informational purposes only and does not constitute medical advice. Your gynecologist should interpret your symptoms, imaging, and biopsy results and advise whether urgent evaluation is needed.